Position
Squarepoint Ops LLC in Pacira BioSciences, Inc.
Back to the book · All holders of PCRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$107.2K$25.88 → $22.60
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 57.3K | $1.48M | — | — | — | 0.0% |
| Q1 2026 | 32.7K | $738.7K | $22.60 | −$107.2K | −$638.3K | 0.0% |